These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30034611)

  • 21. [The main results of clinical trials of the efficacy, safety and pharmacokinetics of the perspective anti-tuberculosis drug makozinone (PBTZ169)].
    Mariandyshev AO; Khokhlov AL; Smerdin SV; Shcherbakova VS; Igumnova OV; Ozerova IV; Bolgarina AA; Nikitina NA
    Ter Arkh; 2020 Apr; 92(3):61-72. PubMed ID: 32598795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors.
    Shakya N; Srivastav NC; Bhavanam S; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    Bioorg Med Chem; 2012 Jul; 20(13):4088-97. PubMed ID: 22664188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel 1,3,4-oxadiazoles as antitubercular agents with limited activity against drug-resistant tuberculosis.
    Makane VB; Krishna VS; Krishna EV; Shukla M; Mahizhaveni B; Misra S; Chopra S; Sriram D; Azger Dusthackeer VN; Rode HB
    Future Med Chem; 2019 Mar; 11(6):499-510. PubMed ID: 30892944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations.
    Naz S; Farooq U; Ali S; Sarwar R; Khan S; Abagyan R
    J Biomol Struct Dyn; 2019 Mar; 37(4):1043-1053. PubMed ID: 29502488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimized Background Regimen for Treatment of Active Tuberculosis with the Next-Generation Benzothiazinone Macozinone (PBTZ169).
    Lupien A; Vocat A; Foo CS; Blattes E; Gillon JY; Makarov V; Cole ST
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of indolopyridone hybrids as new antituberculosis agents.
    Rather MA; Rasool F; Bhat ZS; Dar HU; Maqbool M; Amin S; Yousuf SK; Ahmad Z
    Microb Pathog; 2017 Dec; 113():330-334. PubMed ID: 29079215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diversity oriented design of various hydrazides and their in vitro evaluation against Mycobacterium tuberculosis H37Rv strains.
    Manvar A; Bavishi A; Radadiya A; Patel J; Vora V; Dodia N; Rawal K; Shah A
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4728-31. PubMed ID: 21752642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives.
    Peng CT; Gao C; Wang NY; You XY; Zhang LD; Zhu YX; Xv Y; Zuo WQ; Ran K; Deng HX; Lei Q; Xiao KJ; Yu LT
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1373-6. PubMed ID: 25754492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential of Zanthoxylum leprieurii as a source of active compounds against drug resistant Mycobacterium tuberculosis.
    Bunalema L; Fotso GW; Waako P; Tabuti J; Yeboah SO
    BMC Complement Altern Med; 2017 Feb; 17(1):89. PubMed ID: 28148252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and Biological Evaluation of Hybrid 1,5- and 2,5-Disubstituted Indoles as Potentially New Antitubercular Agents.
    Soares A; Estevao MS; Marques MMB; Kovalishyn V; Latino DARS; Aires-de-Sousa J; Ramos J; Viveiros M; Martins F
    Med Chem; 2017; 13(5):439-447. PubMed ID: 28185538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyrazolo[1,5-a]pyridine-3-carboxamide hybrids: Design, synthesis and evaluation of anti-tubercular activity.
    Lu X; Tang J; Cui S; Wan B; Franzblauc SG; Zhang T; Zhang X; Ding K
    Eur J Med Chem; 2017 Jan; 125():41-48. PubMed ID: 27654393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimycobacterial activity of Citrullus colocynthis (L.) Schrad. against drug sensitive and drug resistant Mycobacterium tuberculosis and MOTT clinical isolates.
    Mehta A; Srivastva G; Kachhwaha S; Sharma M; Kothari SL
    J Ethnopharmacol; 2013 Aug; 149(1):195-200. PubMed ID: 23816500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and in vitro antitubercular evaluation of novel sansanmycin derivatives.
    Li YB; Xie YY; Du NN; Lu Y; Xu HZ; Wang B; Yu Y; Liu YX; Song DQ; Chen RX
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6804-7. PubMed ID: 21982497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and anti-tubercular activity of 2-nitroimidazooxazines with modification at the C-7 position as PA-824 analogs.
    Kang YG; Park CY; Shin H; Singh R; Arora G; Yu CM; Lee IY
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3650-3. PubMed ID: 26199118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and binary QSAR study of antitubercular quinolylhydrazides.
    Manvar A; Khedkar V; Patel J; Vora V; Dodia N; Patel G; Coutinho E; Shah A
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4896-902. PubMed ID: 23876988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, antimalarial and antitubercular activities of meridianin derivatives.
    Yadav RR; Khan SI; Singh S; Khan IA; Vishwakarma RA; Bharate SB
    Eur J Med Chem; 2015 Jun; 98():160-9. PubMed ID: 26005918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spirocyclic and Bicyclic 8-Nitrobenzothiazinones for Tuberculosis with Improved Physicochemical and Pharmacokinetic Properties.
    Zhang G; Howe M; Aldrich CC
    ACS Med Chem Lett; 2019 Mar; 10(3):348-351. PubMed ID: 30891138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles.
    Kamal A; Hussaini SM; Faazil S; Poornachandra Y; Narender Reddy G; Kumar CG; Rajput VS; Rani C; Sharma R; Khan IA; Jagadeesh Babu N
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6842-6. PubMed ID: 24206766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.